Full List Of Stories
Twitter boosted after Citron sets $52 target price
Twitter’s shares were given a boost on Monday after online investment newsletter Citron Research predicted that the social media giant’s shares will hit $52 within a year.
Scotgold sees 'significant advancement' in Loch Lomond mine permitting
Scotgold Resources on Monday told investors that despite delays, "significant advancement" has been made in the permitting process of its Cononish Gold and Silver Mine, near Loch Lomond in Scotland.
FTSE 250 movers: Turkish chaos hits hard but Esure storms higher after offer
London's second-tier index was down 0. 32% at 20,601. 77 in afternoon trade on Monday.
North, South Korean leaders plan third summit for September
North Korean leader Kim Jong Un and South Korean President Moon Jae-in will meet for the third time after the countries on Monday agreed to a September summit in the North’s capital, Pyongyang.
Premier African Minerals gets govt assurances on RHA stake
Premier African Minerals on Monday received positive feedback from the Zimbabwean government regarding the firm’s proposal to increase its holding in RHA Tungsten to 90%.
Reabold seeking quick returns on California project after successful workover
Oil and gas investment company Reabold Resources on Monday confirmed that work is scheduled to commence this week on a California oil licence in which it has an option to invest.
Avesoro swings to profit as gold production soars by 300%
Gold miner Avesoro Resources on Monday swung to a pretax profit for the first half of the year after the firm’s production and sales increased threefold compared to last year.
Oxford Metrics' subsidiary aims to suspend disbelief with VR experiences
International software firm Oxford Metrics’ subsidiary Vicon on Monday launched its collective experience virtual reality (VR) solution, dubbed ‘Origin’.
Bayer plummets after Monsanto's $289m cancer payout
Shares in German pharmaceutical giant Bayer AG plummeted by more than 10% on Monday after subsidiary Monsanto was found to be liable for a terminally ill man’s cancer.